In that study, serum sFRP5 concentration was associated positively with arterial stiffness in patients with type-2 diabetes mellitus, possibly representing a compensatory reaction of sFRP5 to metabolic stress during the early development of atherosclerosis. This evidence concerns the gene SFRP5 and diabetes mellitus.